1977
Medical Graphics Corporation founded by Catherine (Kye) A. Anderson
Medisoft founded by Mr. Guy Martinot
Space Program Testing: NASA’s Johnson Space Center in Houston relies on our Breath-by-Breath gas exchange measurement with the System 2000.
MGC System 2000: exercise system and KEM 2 cycle ergometer.
Advanced Software: developed to provide testing for the Gould and Morgan systems. One of the first companies to add multi-color to the software for ease of reading test data.
1981
PFT System: the Partn’Air is launched and is soon the instrument of choice in Belgium and Northern France.
1983
CAD/NET™ System 2001: assisted an international pharmaceutical firm in evaluating the effectiveness of a new drug based on preventing certain forms of heart disease.
PC Integration: the first company in the region with complete integration of systems to the personal computer (PC).
1985
1985 World’s Fair in Japan: Pulmonary Consult™ was inducted, a sophisticated software program based on algorithms from the principles of artificial intelligence.
1987
Body Plethysmography: the Body 5500 device is added to the range of products. This will later become the best-seller of Medisoft.
1989
Flow Meter System: Branded the preVent™ flow sensor, the foundation of every MGC Diagnostics Product. This product, with some modifications, is still in use today.
CCM/D and CPX/D: upgraded from the DOS operating system to BreezeEx, expanding functionality and improving ease of use.
1991
PF/DX System: A mobile system capable of performing beside PFT testing.
1992
Ultima Series: CCM/D, CPX/D, and CardiO2 were all upgraded.
1996
Gold Standard: Medical Graphics rated industry leader in customer service by a nationally renowned independent consulting firm.
Windows 95™: Advanced software makes the move to Windows 95 – a break from the DOS operating system limitations.
1998
Profiler™: Medical Graphics system combines spirometry, lung volumes and diffusing capacity to give complete testing capabilities.
2001
Construction of New Facility: Medisoft's investment of new facility provides a state-of-the-art production, research & development and centralized office. Site also contains a training facility.
2002
BreezeSuite™: application software designed to combine gas exchange and pulmonary function testing, setting a new standard for ease-of-use.
2004
European Space Agency: retained by the ESA for the development of instrumentation for the study of metabolic function and respiratory function on the International Space Station (ISS).
2007
BreezeSuite WebReview™: workflow solution designed to expedite remote access to test data.
BreezeConnect™ network connection and interfacing to stored cardiorespiratory diagnostic information across multiple testing systems and review stations.
Hyp’Air FeNO: addition enables all General Hospitals to have the ability to perform studies on Exhaled Nitric Oxide for early detection of asthma and enhancing studies to manage treatment.
2009
RAM: acquired Italian company RAM in Padova, Italy, manufacturer of treadmills.
2013
Medical Graphics Corporation (Medgraphics) is rebranded to the MGC Diagnostics you know today.
MGCD's acquisition of Belgium-based Medisoft SA significantly expands business internationally.
2016
Resmon PRO FULL: Entered into an exclusive distribution partnership with ResTech Respiratory Technology for the Resmon PRO™ FULL FOT system for Forced Oscillation Technique.
Ultima Series: latest design of the Ultima Series™ cardiorespiratory diagnostic systems, capable of performing both pulmonary function and metabolic testing in a singular, modular, and upgradeable platform.
Scientific Advisory Committee: formed committee comprised of physicians and scientists to assist in providing advice and guidance on medical and scientific matters related to our business.
Altus Capital Partners: acquisition moves MGCD to a private company and supports the company’s strategies for product innovation and growth.
2019
MSE Medical: acquisition of France-based MSE Medical expands French market and becomes MGC Diagnostics France.
Ascencia: acquisition of Australia-based Ascencia expands South Pacific market and becomes MGC Diagnostics Australia.
2020
Ascent™: cardiorespiratory diagnostic software, designed from the ground up, results in the most advanced testing software platform available.
2021
Lemon Medical: acquisition of Hammelburg, Germany-based Lemon Medical GmbH specializes in cardiorespiratory disposables. Provides MGCD a source of disposables and a significant footprint in the German market - one of the top scientific communities in the world.
PFS Series: Introduced the PFS Series for Medisfot systems utilizing MGC Diagnostics' preVent® flow sensor technology. A major step towards streamlining the two product lines.
2023
CAIRE Inc. acquires MGCD: a Niterra subsidiary, CAIRE acquires MGCD to expand its diagnostic technology offerings and better serve pulmonary disease patients.
2024
Ascent™ Software: designed from the ground up, Ascent™ cardiorespiratory diagnostic software, now for PF and CPET, results in the most advanced testing software platform available.
Home Page
